Citation Impact
Citing Papers
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
2000 Standout
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
The gut microbiota and host health: a new clinical frontier
2015 Standout
Profile of Helicobacter pylori cytotoxin derived from two areas of Japan with different prevalence of atrophic gastritis.
1996
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
2019 Standout
ESUR prostate MR guidelines 2012
2012 Standout
Gastric cancer
2016 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: Role of the sydney system
1999
Classification and Grading of Gastritis
1996 Standout
The Association Between Helicobacter pylori Infection and Early Gastric Cancer: A Meta-Analysis
2007
Cancer burden in the year 2000. The global picture
2001 Standout
Current role of acid suppressants in Helicobacter pylori eradication therapy
2001
Global Cancer Statistics, 2002
2005 Standout
Ulcerative Colitis
2011 Standout
Algorithm for the management of ERCP-related perforations
2015
Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis
2003
Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis
2011
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
2004 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
Crohn's disease
2012 Standout
Mesalamine Once Daily Is More Effective Than Twice Daily in Patients With Quiescent Ulcerative Colitis
2009
Systematic review: the use of mesalazine in inflammatory bowel disease
2006
Esophageal Cancer
2003 Standout
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
2017 Standout
The gastric transitional zones: Neglected links between gastroduodenal pathology and Helicobacter ecology
1999
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
2001 Standout
High acid secretion may protect the gastric mucosa from injury caused by ammonia produced by Helicobacter pylori in duodenal ulcer patients
1996
Global cancer transitions according to the Human Development Index (2008–2030): a population-based study
2012 Standout
Family history and subsite of gastric cancer: Data from a case-referent study in Japan
1998
Helicobacter pylori Infection and the Development of Gastric Cancer
2001 Standout
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial
1999 Standout
Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori
1998
Atrophic Gastritis and Intestinal Metaplasia in Japan: Results of a Large Multicenter Study
2001
Ulcerative colitis
2012 Standout
Crohn's disease
2016 Standout
Helicobacter pylori infection induces gastric cancer in Mongolian gerbils
1998 Standout
Gastric cancer in the European Union (1968–1992): Mortality trends and cohort effect
1997
A 5‐decade analysis of 13,715 carcinoid tumors
2003 Standout
Modification effects of GSTM1, GSTT1 and CYP2E1 polymorphisms on associations between raw salted food and incomplete intestinal metaplasia in a high‐risk area of stomach cancer
2003
Helicobacter pylori Infection and Gastric Lymphoma
1994 Standout
Biopsy Sites Suitable for the Diagnosis of Helicobacter pylori Infection and the Assessment of the Extent of Atrophic Gastritis
1998
Long-Term Effects of Helicobacter pylori Eradication on Intestinal Metaplasia in Patients with Duodenal and Benign Gastric Ulcers
2000
Management of endoscopic retrograde cholangiopancreatography-related perforation
2008
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2012
Ulcerative colitis
2016 Standout
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
2010
Vegetables, fruit and risk of gastric cancer in Japan: A 10‐year follow‐up of the JPHC study Cohort I
2002
Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis
2008
Gastric cancer
2020 Standout
Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils treated with chemical carcinogens
1999
Validity of Clinical Criteria in the Management of Endoscopic Retrograde Cholangiopancreatography–Related Duodenal Perforations
2007
Life‐style and subsite of gastric cancer—joint effect of smoking and drinking habits
1994
An analysis of 8305 cases of carcinoid tumors
2000 Standout
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
2012
Pathophysiological effects of long-term acid suppression in man
1995
Personal History and Family History as a Predictor of Gastric Cardiac Adenocarcinoma Risk: A Case-Control Study in Taiwan
2004
How Do Practicing Clinicians Manage Helicobacter pylori‐Related Gastrointestinal Diseases in Germany? A Survey of Gastroenterologists and Family Practitioners
1998
Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China
2004 Standout
Management of duodenal and pancreaticobiliary perforations associated with periampullary endoscopic procedures
2008
Helicobacter pylori in promotion of gastric carcinogenesis
1996
5-Aminosalicylates and renal function in inflammatory bowel disease
2007
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis
2010
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
2011
Prognostic Value of Laurén Classification and c-erbB-2 Oncogene Overexpression in Adenocarcinoma of the Esophagus and Gastroesophageal Junction
1999
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
2016
Adverse events associated with ERCP
2016 Standout
Commensal Host-Bacterial Relationships in the Gut
2001 StandoutScience
Management of Duodenal Perforation Post-Endoscopic Retrograde Cholangiopancreatography. When and Whom to Operate and What Factors Determine The Outcome? A Review Article
2011
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Helicobacter pylori gastritis and primary gastric non-Hodgkin's lymphomas.
1994
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
2004 Standout
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
How Do Clinicians Practicing in the U.S. Manage Helicobacter pylori-Related Gastrointestinal Diseases? A Comparison of Primary Care and Specialist Physicians
1998
Increased prevalence of Helicobacter pylori infection among patients affected with intestinal‐type gastric cancer at non‐cardiac locations
1997
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial
2003 Standout
A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn’s Disease Flares
2019 Standout
Quality indicators for colonoscopy
2014 Standout
Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori.
1995
Unchanged survival of gastric cancer in the southeastern netherlands since 1982: Result of differential trends in incidence according to laur�n type and subsite
1999
HELICOBACTER PYLORI–ASSOCIATED GASTRIC PATHOLOGY
1993
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
Classification and management of perforations complicating endoscopic sphincterotomy
1999
European evidence-based Consensus on the management of ulcerative colitis: Current management
2008
Endoscopic Retrograde Cholangiopancreatography Gut Perforations: When to Wait! When to Operate!
2009
Epidemiology of gastric cancer
2006 Standout
Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability.
1999
Works of J Ferwerda being referenced
Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum.
1992
CT before and after ERCP: detection of pancreatic pseudotumor, asymptomatic retroperitoneal perforation, and duodenal diverticulum
1997
Comparison of the efficacy and safety of 1.5 compared with 3.0 g oral slow-release mesalazine (Pentasa) in the maintenance treatment of ulcerative colitis
1995
Time trends in gastric carcinoma: changing patterns of type and location.
1992
Subtypes of intestinal metaplasia and Helicobacter pylori.
1992